InvestorsHub Logo

esad1

01/09/17 12:54 PM

#33921 RE: gilbe #33918

Thanks I did not see it....FDA as usual is foot dragging and the onus is on the company to validate one of the many opportunities it has going forward. The market rewards reality.

stevo99

01/09/17 5:49 PM

#33925 RE: gilbe #33918

how come Chardan didn't mention China or current sales of XXII's products in Europe and US? 2 cent report or those things aren't worth talking about?

Big bucks

01/12/17 12:41 PM

#33968 RE: gilbe #33918

again, the same ole same ole.... nothing new folks...its all about this mgmt. team receiving huge salaries for zero progress....with all the business moving into MJ as XXII has....why in the world wouldn't you put more emphasis toward MJ.....my God, no partnerships, old CEO manipulated stock, more money will be needed and sales are looking very weak....wouldn't doubt it one bit if we see a revenue decrease..... yup, decrease.....you would think this company would have it down by now..... you all recall the many conference calls with the CEO....... its progress or get out and let another CEO come in.... this guy has been all talk..

GET READY FOR MORE DILUTION FOLKS..... YIKES!